PARP4 and ovarian carcinoma: Similarly, Youn Sung et al. [55] analyzed PARP4 mRNA expression profiles in ovarian cancer cell lines, confirming that it is upregulated in cisplatin-sensitive cells compared to cisplatin-resistant cells.